Alloplex Biotherapeutics Inc
1 clinical trials · Sponsor
◉ Watch Alloplex Biotherapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies (NCT05237206) | Alloplex Biotherapeutics Inc | 2022-04-28 |
Track Alloplex Biotherapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.